Rock Edwin 4
4 · GLYCOMIMETICS INC · Filed Nov 16, 2022
Insider Transaction Report
Form 4
Rock Edwin
Chief Medical Officer
Transactions
- Purchase
Common Stock
2022-11-15$1.66/sh+100,000$166,000→ 200,000 total - Purchase
Common Stock
2022-11-14$1.43/sh+100,000$143,000→ 100,000 total
Footnotes (2)
- [F1]The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.31 to $1.55 per share, with a weighted average purchase price of $1.43 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]The Reporting Person purchased the securities on the open market at purchase prices ranging from $1.52 to $1.75 per share, with a weighted average purchase price of $1.66 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.